These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 29436260)

  • 41. Burden of illness in patients with pulmonary hypertension due to interstitial lung disease: a real-world analysis.
    Heresi G; Dean B; Wu B; Lee H; Sketch MR; Stafkey-Mailey D; Morland K; Classi P; Spikes L
    BMC Pulm Med; 2024 Jul; 24(1):335. PubMed ID: 38992626
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone.
    Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D
    J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic burden of major bleeding events in commercially insured patients with von Willebrand disease based on claims data from the United States.
    Lu M; Oladapo A; Wu Y; Farahbakhshian S; Ewenstein B
    J Manag Care Spec Pharm; 2021 Feb; 27(2):175-185. PubMed ID: 33307935
    [No Abstract]   [Full Text] [Related]  

  • 44. The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States.
    Ogbomo A; Tsang Y; Mallampati R; Panjabi S
    J Manag Care Spec Pharm; 2022 Jun; 28(6):608-616. PubMed ID: 35621726
    [No Abstract]   [Full Text] [Related]  

  • 45. Retrospective database analysis of the impact of prior authorization for type 2 diabetes medications on health care costs in a Medicare Advantage Prescription Drug Plan population.
    Bergeson JG; Worley K; Louder A; Ward M; Graham J
    J Manag Care Pharm; 2013 Jun; 19(5):374-84. PubMed ID: 23697475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic burden and antidepressant treatment patterns among patients with major depressive disorder in the United States.
    Zhu L; Ferries E; Suthoff E; Namjoshi M; Bera R
    J Manag Care Spec Pharm; 2022 Nov; 28(11-a Suppl):S2-S13. PubMed ID: 36242598
    [No Abstract]   [Full Text] [Related]  

  • 47. Healthcare resource utilization and cost among patients with type 1 diabetes in the United States.
    Simeone JC; Shah S; Ganz ML; Sullivan S; Koralova A; LeGrand J; Bushman J
    J Manag Care Spec Pharm; 2020 Nov; 26(11):1399-1410. PubMed ID: 33119443
    [No Abstract]   [Full Text] [Related]  

  • 48. Health Care Resource Utilization and Costs Associated with Corticosteroid Use in Patients with Castration-Resistant Prostate Cancer: An Administrative Claims Analysis.
    Schultz NM; Penson DF; Wilson SD; Song Y; Yang H; Ramaswamy K; Lowentritt B
    J Manag Care Spec Pharm; 2019 Aug; 25(8):889-897. PubMed ID: 31172866
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Place of care and costs associated with acute episodes and remission in schizophrenia.
    McIntyre RS; Higa S; Doan QV; Amari DT; Mercer D; Gillard P; Harrington A
    J Manag Care Spec Pharm; 2023 May; 29(5):499-508. PubMed ID: 37121252
    [No Abstract]   [Full Text] [Related]  

  • 50. Analysis of Adherence, Persistence, and Surgery Among Endometriosis Patients Treated with Leuprolide Acetate Plus Norethindrone Acetate Add-Back Therapy.
    Soliman AM; Bonafede M; Farr AM; Castelli-Haley J; Winkel C
    J Manag Care Spec Pharm; 2016 May; 22(5):573-87. PubMed ID: 27123918
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Real-World Treatment Patterns and Costs for Patients with Renal Cell Carcinoma Initiating Treatment with Sunitinib and Pazopanib.
    MacLean E; Mardekian J; Cisar LA; Hoang CJ; Harnett J
    J Manag Care Spec Pharm; 2016 Aug; 22(8):979-90. PubMed ID: 27459661
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of a Patient Support Program on Patient Adherence to Adalimumab and Direct Medical Costs in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriasis, Psoriatic Arthritis, and Ankylosing Spondylitis.
    Rubin DT; Mittal M; Davis M; Johnson S; Chao J; Skup M
    J Manag Care Spec Pharm; 2017 Aug; 23(8):859-867. PubMed ID: 28737994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Comparison of Health Care Resource Utilization and Costs for Patients with Allergic Rhinitis on Single-Product or Free-Combination Therapy of Intranasal Steroids and Intranasal Antihistamines.
    Harrow B; Sedaghat AR; Caldwell-Tarr A; Dufour R
    J Manag Care Spec Pharm; 2016 Dec; 22(12):1426-1436. PubMed ID: 27882840
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluating the Effect of Treatment Persistence on the Economic Burden of Moderate to Severe Psoriasis and/or Psoriatic Arthritis Patients in the U.S. Department of Defense Population.
    Lee S; Xie L; Wang Y; Vaidya N; Baser O
    J Manag Care Spec Pharm; 2018 Jul; 24(7):654-663. PubMed ID: 29952710
    [TBL] [Abstract][Full Text] [Related]  

  • 55. All-cause health care utilization and costs associated with newly diagnosed multiple sclerosis in the United States.
    Asche CV; Singer ME; Jhaveri M; Chung H; Miller A
    J Manag Care Pharm; 2010; 16(9):703-12. PubMed ID: 21067256
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease-related and all-cause health care costs of elderly patients with gout.
    Wu EQ; Patel PA; Yu AP; Mody RR; Cahill KE; Tang J; Krishnan E
    J Manag Care Pharm; 2008 Mar; 14(2):164-75. PubMed ID: 18331118
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Direct health care costs associated with COVID-19 in the United States.
    DeMartino JK; Swallow E; Goldschmidt D; Yang K; Viola M; Radtke T; Kirson N
    J Manag Care Spec Pharm; 2022 Sep; 28(9):936-947. PubMed ID: 35722829
    [No Abstract]   [Full Text] [Related]  

  • 58. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Real-World Axitinib Use in the United States: A Retrospective Study Using Linked Datasets.
    MacLean E; Cisar L; Mehle K; Eremina D; Quigley JM
    J Manag Care Spec Pharm; 2016 Jun; 22(6):723-732u. PubMed ID: 27231799
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Health Care Resource Utilization and Cost Before Initial Schizophrenia Diagnosis.
    Wallace A; Barron J; York W; Isenberg K; Franchino-Elder J; Sidovar M; Sand M
    J Manag Care Spec Pharm; 2019 Oct; 25(10):1102-1110. PubMed ID: 31556820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.